FDA
approval
· 2023-08-18
FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
The FDA approved a supplemental application for Citalopram from Hikma Pharmaceuticals USA Inc., related to a generic form of the antidepressant. The action conf…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CITALOPRAM (CITALOPRAM)